4.6 Article

Multiparametric MRI radiomics fusion for predicting the response and shrinkage pattern to neoadjuvant chemotherapy in breast cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Radiology, Nuclear Medicine & Medical Imaging

Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer

Yanbo Li et al.

Summary: A nomogram based on pretreatment DCE-MRI was developed to predict pCR after NAC in TNBC patients. Tumor volume on DCE-MRI, TTP, and AR status were identified as independent predictors of pCR. The nomogram showed good predictive performance in both the primary and validation cohorts.

EUROPEAN RADIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study

Ming Fan et al.

Summary: This study utilized radiogenomics to explore the association between imaging features and genomic assays in estrogen receptor-positive breast cancer. It identified radiogenomic signatures that may serve as prognostic features and treatment response biomarkers.

RADIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy

Na Lae Eun et al.

Summary: Texture analysis using MRI can predict recurrence in breast cancer patients treated with neoadjuvant chemotherapy, with higher diagnostic performance compared to common features analysis.

EUROPEAN RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Breast MRI for Evaluation of Response to Neoadjuvant Therapy

Beatriu Reig et al.

Summary: Neoadjuvant therapy is increasingly used for various types of breast cancer to shrink tumors, test treatment response, and provide prognostic information. MRI is the most accurate modality to show treatment response, but may overestimate or underestimate residual disease.

RADIOGRAPHICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram

Soo-Yeon Kim et al.

Summary: A nomogram incorporating MRI and clinical-pathologic variables was developed to predict pathologic complete response after neoadjuvant chemotherapy in breast cancer. The nomogram showed good discrimination and calibration abilities, effectively identifying independent variables associated with pCR.

RADIOLOGY (2021)

Article Biochemistry & Molecular Biology

Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer

Ming Fan et al.

Summary: Breast tumor morphological and vascular characteristics can change during neoadjuvant chemotherapy (NACT), with early changes in tumor heterogeneity being quantitatively modeled using DCE-MRI to predict responses. Radiomics merging clinical and feature-level changes, when combined with molecular subtype information, significantly improves predictive performance in assessing breast tumor response to NACT.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biotechnology & Applied Microbiology

Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer

Yuhong Huang et al.

Summary: The study aimed to predict tumor shrinkage patterns prior to NACT using a machine learning model that combines radiomics features and clinical characteristics. Results showed that the Multilayer Perception neural network achieved higher AUC and accuracy than other classifiers and performed well in different molecular subtypes of breast cancer, indicating its potential in guiding NACT and surgical treatment in breast cancer.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer

Na Lae Eun et al.

RADIOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer

Beatriu Reig et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)

Review Chemistry, Medicinal

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Huan Wang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Review Oncology

Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy

P. Taourel et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients

Ming Fan et al.

EUROPEAN JOURNAL OF RADIOLOGY (2017)

Article Oncology

Computational Radiomics System to Decode the Radiographic Phenotype

Joost J. M. van Griethuysen et al.

CANCER RESEARCH (2017)

Article Oncology

Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer

Xi Gu et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis

A. Karahaliou et al.

BRITISH JOURNAL OF RADIOLOGY (2010)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)